Stock Events

Stock Events

Check-Cap 

$1.61
80
+$0.03+1.9% Wednesday 21:00

Statistics

Day High
1.67
Day Low
1.5
52W High
3.13
52W Low
0.56
Volume
42,004
Avg. Volume
2,977,962
Mkt Cap
9.42M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

22NovExpected
Q3 2022
Q4 2022
Q2 2023
Q3 2023
Q1 2024
Q2 2024
Q3 2024
-0.98
-0.67
-0.35
-0.04
Expected EPS
-0.17
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-50.3MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CHEK. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
EXACT Sciences
EXAS
Mkt Cap20.03B
Exact Sciences offers Cologuard, a non-invasive colon cancer screening test, directly competing with Check-Cap's capsule-based screening technology.
Intuitive Surgical
ISRG
Mkt Cap160.56B
Intuitive Surgical specializes in robotic-assisted surgery, offering an alternative to Check-Cap's non-invasive approach by providing minimally invasive surgical options.
Medtronic
MDT
Mkt Cap111.22B
Medtronic offers a broad range of medical devices that include gastrointestinal and endoscopic products, competing with Check-Cap in the broader market for diagnostic solutions.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific produces endoscopy equipment and devices, offering competitive technologies for diagnosing and managing gastrointestinal conditions.
Guardant Health
GH
Mkt Cap12.31B
Guardant Health offers liquid biopsy tests for cancer detection, providing a non-invasive alternative to traditional and emerging diagnostic methods, including Check-Cap's.
NovoCure
NVCR
Mkt Cap1.2B
NovoCure develops treatment for cancer using Tumor Treating Fields, a different approach but competes for the same oncology market as Check-Cap's diagnostic solutions.
Stryker
SYK
Mkt Cap126.97B
Stryker specializes in medical technologies, including endoscopic and surgical devices, competing in the broader market for medical devices that can be used in diagnosis and treatment of gastrointestinal diseases.

About

Check-Cap Ltd., a clinical stage medical diagnostics company, focuses on capsule-based screening technology products. The company was incorporated in 2004 and is based in Isfiya, Israel.
Show more...
CEO
Mr. David Lontini
Employees
85
Country
United States
ISIN
IL0011336851

Listings

STU
DE
7CC.STU
MU
DE
7CC.MU
F
DE
7CC.F
BOATS
BOATS
MBAI.BOATS

0 Comments

Share your thoughts

FAQ

What is Check-Cap stock price today?▼
The current price of CHEK is $1.61 USD — it has increased by +1.9% in the past 24 hours. Watch Check-Cap stock price performance more closely on the chart.
What is Check-Cap stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Check-Cap stocks are traded under the ticker CHEK.
Is Check-Cap stock price growing?▼
CHEK stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Check-Cap has showed a +138.34% increase.
What is Check-Cap market cap?▼
Today Check-Cap has the market capitalization of 9.42M
What is Check-Cap revenue for the last year?▼
Check-Cap revenue for the last year amounts to 0 USD.
What is Check-Cap net income for the last year?▼
CHEK net income for the last year is -50.3M USD.
How many employees does Check-Cap have?▼
As of April 11, 2026, the company has 85 employees.
In which sector is Check-Cap located?▼
Check-Cap operates in the Health & Wellness sector.
When did Check-Cap complete a stock split?▼
The last stock split for Check-Cap was on November 25, 2022 with a ratio of 1:20.
Where is Check-Cap headquartered?▼
Check-Cap is headquartered in Isfiya, United States.